Archive | Conferences & Symposiums

Uveal melanoma prognoses vary depending on genomic subset

Four molecularly distinct subtypes of uveal melanomas have been identified, two with poorer prognosis and two with better prognosis, according to a study.

Read the full story

Posted in Melanoma In The News, Conferences & Symposiums

Researchers develop new melanoma treatment

It’s estimated that one Australian dies of melanoma every five hours. It’s among the most commonly diagnosed cancers in Australia — and the most deadly.

Read the full story

Posted in Melanoma In The News, Conferences & Symposiums

Challenges in melanoma clinical research: A snapshot from the Australasian Melanoma Conference 2016

The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.

Read the full story

Posted in Melanoma In The News, Conferences & Symposiums, Information

ASCO Daily News

Immunotherapies and targeted therapies have been approved for the treatment of metastatic melanoma based on clinical studies. However, in clinical practice, it is not easy to contextualize clinical study data. “Important issues arise when treating real world patients with immunotherapies,” said session chair John B. A. G. Haanen, MD, PhD, of the Netherlands Cancer Institute.

Read the full story

Posted in Melanoma In The News, Conferences & Symposiums

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories